MSc in Molecular Medicine

The objective of the programme is to produce highly competent clinical and medical scientists as well as researchers and professionals in the health and life sciences who are well-equipped with up-to date knowledge and understanding of the advancement in molecular medicine.

Applicants are required to have obtained:

• A bachelor’s degree with minimum CGPA of 2.75 or equivalent, as accepted by the HEP Senate; or
• A bachelor’s degree or equivalent with minimum CGPA of 2.50 and not meeting CGPA of 2.75, can be accepted subject to rigorous internal assessment; or
• A bachelor’s degree or equivalent not meeting CGPA of 2.50, can be accepted subject to a minimum of 5 years working experience in relevant field.

The IMU MSc Molecular Medicine programme consists of 2 semesters of coursework followed by a research project in the third semester. New semesters commence in March and September each year.
While all coursework classes are conducted on weekends to accommodate students that have personal or work commitment on weekdays; students that undertake the research project in the final semester would be required to be physically based at IMU. The minimum completion duration for the programme is 18 months and maximum is 4 years. A student must complete 40 credits (15 credits from core coursework modules, 5 from selective coursework modules and 20 from research project) to graduate.

Core modules are as follows:

Molecular Medicine (3 credit)
Immunology and Infection (2 credit)
Molecular Basis of Diseases 1 (3 credit)
Molecular Basis of Diseases 2 (4 credit)
Research Methodology and Scientifi c Writing (3 credit)
Research Project (20 credit)

Selective modules are as follows:

Bench to Market (2 credit)
Bioinformatics (3 credit)
Clinical Research 1 (2 credit)
Clinical Research 2 (2 credit)
Laboratory Management (2 credit)
Stem Cell Technology and Therapeutics (3 credit)
Drug Discovery, Design and Development (3 credit)

Semester contents are available in the programme brochure [Download Brochure]

Teaching and learning activities include lectures, case studies, workshops, seminars, presentation, assignments, discussions and tutorials.

In course assessment throughout the programme via written reports (case study report, critical reviews, assignments, CAL reports, scientifi c writing and etc.) and oral presentations in all coursework modules. Research dissertation, presentations and viva voce are used to assess research project. There are no end-of-semester examinations for all modules.

Teaching and learning activities comprise both conventional and blended learning approaches integrated into lectures, case studies, workshops, seminars, presentations, assignments, discussions and tutorials. There are no laboratory practical in each coursework module, except in the research project.

• The programme is delivered through insightful and innovative research-driven approach by our experienced and internationally acclaimed faculty who are enthusiastic about sharing their vast experiences in molecular medicine.
• Every student will have the opportunity to spend a minimum of six months engaging in a research project in any one of the IMU research thrust areas, in particular, bioactive molecules, drug discovery and delivery, population health as well as cancer and stem cells.
• We have close research collaboration with researchers from our partner universities. Students would have opportunities to conduct their research in one of our partner universities in the United Kingdom, Australia or New Zealand.
• Research and teaching activities are supported by cutting edge facilities and well equipped modern research laboratories.
• Students who are in full-time employment have the option of attending the course part-time due to the modular format of the programme. It may also be possible for them to conduct their respective research project at their workplace.